Skip to main content
FDA Shortage Check

Is Adderall (Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Adderall: in shortage (FDA, Oct 24)

Tablets
A generic tablet, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Epic Pharma, LLC, Oct 23, 2026
DRUG
Adderall
FDA LISTING
FORM
tablets
STATUS
Currently in Shortage
FIRST POSTED
Oct 12, 2022
LAST FDA UPDATE
Oct 23, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 73 presentations: 19 unavailable · 9 limited · 45 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet. 73 presentations from 11 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Aurobindo Pharma USA6 presentations · 6 unavailable

Contact (FDA's listing): (866) 850-2876 or CustomerService@AurobindoUSA.com

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01)

    Estimated availability: April 2027

    NDC 13107-068-01Revised

    Unavailable

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01)

    Estimated availability: April 2027

    NDC 13107-069-01Revised

    Unavailable

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)

    Estimated availability: April 2027

    NDC 13107-070-01Revised

    Unavailable

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)

    Estimated availability: April 2027

    NDC 13107-072-01Revised

    Unavailable

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01)

    Estimated availability: April 2027

    NDC 13107-073-01Revised

    Unavailable

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01)

    Estimated availability: April 2027

    NDC 13107-074-01Revised

    Unavailable

Epic Pharma, LLC5 presentations · 5 limited

Contact (FDA's listing): (718) 276-8600 ext. 3

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)

    Estimated recovery: TBD

    NDC 42806-339-01Reverified

    Limited Availability

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01)

    Estimated recovery: TBD

    NDC 42806-341-01Reverified

    Limited Availability

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01)

    Estimated recovery: TBD

    NDC 42806-343-01Reverified

    Limited Availability

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01)

    Estimated recovery: TBD

    NDC 42806-344-01Reverified

    Limited Availability

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)

    Estimated recovery: TBD

    NDC 42806-345-01Reverified

    Limited Availability

Granules Pharmaceuticals Inc.7 presentations · 7 unavailable

Contact (FDA's listing): 877-770-3183

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)

    Estimated recovery: October 2026

    NDC 70010-111-01Reverified

    Unavailable

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01)

    Estimated recovery: October 2026

    NDC 70010-112-01Reverified

    Unavailable

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)

    Estimated recovery: October 2026

    NDC 70010-113-01Reverified

    Unavailable

  • 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01)

    Estimated recovery: October 2026

    NDC 70010-114-01Reverified

    Unavailable

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01)

    Estimated recovery: October 2026

    NDC 70010-115-01Reverified

    Unavailable

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01)

    Estimated recovery: October 2026

    NDC 70010-116-01Reverified

    Unavailable

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01)

    Estimated recovery: October 2026

    NDC 70010-117-01Reverified

    Unavailable

Oryza Pharmaceuticals Inc.5 presentations · 5 unavailable

Contact (FDA's listing): 855-257-0292

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)

    Estimated recovery: April 2027

    NDC 72516-016-01Reverified

    Unavailable

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)

    Estimated recovery: April 2027

    NDC 72516-014-01Reverified

    Unavailable

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01)

    Estimated recovery: April 2027

    NDC 72516-013-01Reverified

    Unavailable

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)

    Estimated recovery: April 2027

    NDC 72516-012-01Reverified

    Unavailable

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)

    Estimated recovery: April 2027

    NDC 72516-011-01Reverified

    Unavailable

SpecGx LLC6 presentations · 3 limited · 3 available or not stated

Contact (FDA's listing): 800-325-8888

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)

    Estimated recovery: TBD

    NDC 0406-8891-01Revised

    Limited Availability

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)

    Estimated recovery: TBD

    NDC 0406-8892-01Revised

    Limited Availability

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)

    Estimated recovery: TBD

    NDC 0406-8894-01Revised

    Limited Availability

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)

    NDC 0406-8884-01Reverified

    Available

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)

    NDC 0406-8885-01Reverified

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)

    NDC 0406-8893-01Reverified

    Available

Teva Pharmaceuticals USA, Inc.14 presentations · 1 unavailable · 1 limited · 12 available or not stated

Contact (FDA's listing): 800-545-8800

  • 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg

    Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)

    Estimated recovery: November 2026

    NDC 57844-112-01Revised

    Unavailable

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)

    Estimated recovery: TBD

    NDC 0555-0974-02Revised

    Limited Availability

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)

    NDC 57844-105-01Reverified

    Available

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)

    NDC 57844-117-01Reverified

    Available

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)

    NDC 57844-110-01Reverified

    Available

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)

    NDC 57844-115-01Reverified

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)

    NDC 57844-120-01Reverified

    Available

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)

    NDC 57844-130-01Reverified

    Available

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)

    NDC 0555-0971-02Reverified

    Available

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)

    NDC 0555-0775-02Reverified

    Available

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)

    NDC 0555-0972-02Reverified

    Available

  • 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)

    NDC 0555-0776-02Reverified

    Available

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)

    NDC 0555-0777-02Revised

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)

    NDC 0555-0973-02Reverified

    Available

Alvogen5 presentations · 5 available or not stated

Contact (FDA's listing): 844-842-8672 and email: CustomerService-US@alvogen.com

  • 10mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01)

    NDC 47781-176-01Reverified

    Available

  • 15mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01)

    NDC 47781-178-01Reverified

    Available

  • 20mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01)

    NDC 47781-179-01Reverified

    Available

  • 30mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01)

    NDC 47781-180-01Reverified

    Available

  • 5mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01)

    NDC 47781-174-01Reverified

    Available

Elite Laboratories, Inc.7 presentations · 7 available or not stated

Contact (FDA's listing): 888-852-6657

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01)

    NDC 64850-500-01Reverified

    Available

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01)

    NDC 64850-501-01Reverified

    Available

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01)

    NDC 64850-502-01Reverified

    Available

  • 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01)

    NDC 64850-503-01Reverified

    Available

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)

    NDC 64850-504-01Reverified

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01)

    NDC 64850-505-01Reverified

    Available

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01)

    NDC 64850-506-01Reverified

    Available

Lannett Company, Inc.7 presentations · 7 available or not stated

Contact (FDA's listing): 844-834-0530

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37)

    NDC 0527-0760-37Reverified

    Available

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37)

    NDC 0527-0761-37Reverified

    Available

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)

    NDC 0527-1502-37Reverified

    Available

  • 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37)

    NDC 0527-0763-37Reverified

    Available

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37)

    NDC 0527-0764-37Reverified

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)

    NDC 0527-1505-37Reverified

    Available

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37)

    NDC 0527-0766-37Reverified

    Available

Sandoz Inc.4 presentations · 4 available or not stated

Contact (FDA's listing): 800-525-8747

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)

    NDC 0185-2098-01Reverified

    Available

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)

    NDC 0185-0842-01Reverified

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)

    NDC 0185-0853-01Reverified

    Available

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)

    NDC 0185-2099-01Reverified

    Available

Sunrise Pharmaceutical, Inc.7 presentations · 7 available or not stated

Contact (FDA's listing): 732-382-6085 Monday to Friday 9 am to 3:45 pm

  • 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01)

    NDC 11534-190-01Reverified

    Available

  • 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01)

    NDC 11534-191-01Reverified

    Available

  • 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01)

    NDC 11534-192-01Reverified

    Available

  • 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01)

    NDC 11534-193-01Reverified

    Available

  • 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01)

    NDC 11534-194-01Reverified

    Available

  • 5 mg; 5 mg; 5 mg; 5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01)

    NDC 11534-195-01Reverified

    Available

  • 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01)

    NDC 11534-196-01Reverified

    Available

What the manufacturers told FDA

  • Epic Pharma, LLC · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Granules Pharmaceuticals Inc. · ‘Estimated recovery: October 2026’ · updated Oct 2026
  • Oryza Pharmaceuticals Inc. · ‘Estimated recovery: April 2027’ · updated Oct 2026
  • SpecGx LLC · ‘Estimated recovery: TBD’ · updated Aug 2026
  • Teva Pharmaceuticals USA, Inc. · ‘Estimated recovery: November 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other
  • Shortage of an active ingredient

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Adderall in shortage?
Yes. As of Oct 24, 2026, FDA lists Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet as currently in shortage: 73 presentations, 19 unavailable and 9 limited.
When will the Adderall shortage end?
FDA gives no end date. 22 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Adderall?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.